VolitionRX Ltd. (VNRX)
0.235
0.00 (0.00%)
USD |
NYAM |
Oct 02, 16:00
0.2332
0.00 (0.00%)
After-Hours: 20:00
VolitionRX Net Income (Quarterly) : -7.775M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.775M |
| March 31, 2026 | -6.704M |
| December 31, 2025 | -6.303M |
| September 30, 2025 | -5.410M |
| June 30, 2025 | -6.314M |
| March 31, 2025 | -5.477M |
| December 31, 2024 | -5.857M |
| September 30, 2024 | -5.869M |
| June 30, 2024 | -7.060M |
| March 31, 2024 | -8.472M |
| December 31, 2023 | -8.800M |
| September 30, 2023 | -8.453M |
| June 30, 2023 | -9.551M |
| March 31, 2023 | -8.873M |
| December 31, 2022 | -7.336M |
| September 30, 2022 | -7.812M |
| June 30, 2022 | -7.732M |
| March 31, 2022 | -7.718M |
| December 31, 2021 | -8.108M |
| September 30, 2021 | -7.182M |
| June 30, 2021 | -5.574M |
| March 31, 2021 | -6.126M |
| December 31, 2020 | -5.161M |
| September 30, 2020 | -4.336M |
| June 30, 2020 | -5.043M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.859M |
| December 31, 2019 | -3.557M |
| September 30, 2019 | -4.181M |
| June 30, 2019 | -4.157M |
| March 31, 2019 | -4.204M |
| December 31, 2018 | -4.288M |
| September 30, 2018 | -4.477M |
| June 30, 2018 | -4.592M |
| March 31, 2018 | -4.652M |
| December 31, 2017 | -4.063M |
| September 30, 2017 | -3.893M |
| June 30, 2017 | -3.463M |
| March 31, 2017 | -3.351M |
| December 31, 2016 | -2.984M |
| September 30, 2016 | -3.479M |
| June 30, 2016 | -2.949M |
| March 31, 2016 | -2.493M |
| December 31, 2015 | -2.687M |
| September 30, 2015 | -2.963M |
| June 30, 2015 | -1.871M |
| March 31, 2015 | -2.010M |
| December 31, 2014 | -0.942M |
| September 30, 2014 | -5.894M |
| June 30, 2014 | 0.8168M |
| March 31, 2014 | -2.194M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 338.41M |
| Neogen Corp. | -11.30M |
| QuidelOrtho Corp. | -92.90M |
| Aspira Women's Health, Inc. | -2.42M |
| Lucid Diagnostics, Inc. | -11.69M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.3987M |
| Total Expenses (Quarterly) | 8.185M |
| EPS Diluted (Quarterly) | -0.8505 |
| Enterprise Value | 10.08M |
| Gross Profit Margin (Quarterly) | 28.37% |
| Profit Margin (Quarterly) | -1.95K% |
| Earnings Yield | -1.63K% |
| Normalized Earnings Yield | -1524.47 |